Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Debopam Samanta to Epilepsies, Myoclonic

This is a "connection" page, showing publications Debopam Samanta has written about Epilepsies, Myoclonic.

 
Connection Strength
  
 
 
2.450
  
  1. Samanta D. Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics. 2020 04; 51(2):135-145.
    View in: PubMed
    Score: 0.729
  2. Samanta D. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatr Neurol. 2019 07; 96:24-29.
    View in: PubMed
    Score: 0.684
  3. Samanta D. Sinus pericranii and myoclonic epilepsy: novel features of 3q29 microdeletion syndrome. Acta Neurol Belg. 2016 Sep; 116(3):363-4.
    View in: PubMed
    Score: 0.540
  4. Samanta D, Ramakrishnaiah R, Willis E, Frye RE. Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation. Acta Neurol Belg. 2015 Sep; 115(3):475-8.
    View in: PubMed
    Score: 0.497
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.